New Cell Therapeutics Presentation
July 9, 2009 at 11:27 am EST | Tags: Clinical Trials, Filings & Approvals, Gossip & Rumors
This was just sent to us from an anonymous source.
After some searching, we found that the ppt was already available right here – on the borsaitaliana.it website.
There’s not much new to be seen, but we can finally get confirmation of the royalties Novartis (NVS) would pay to CTIC for pixantrone — 28% to 32% on net sales beyond $50 million.
No idea what they get if sales are less than $50 million.
Check it out…
Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
awesome post!!!!